MEDNAX Announces Leadership and Board Transitions

July 13, 2020

Cleary Gottlieb advised MEDNAX Inc. (MEDNAX), which announced that its board of directors has appointed Mark S. Ordan as Chief Executive Officer, succeeding Roger J. Medel, M.D., the company’s founder.

Dr. Medel will remain a member of the board until the 2021 Annual Meeting of Shareholders.

MEDNAX also announced that its board has appointed five new directors: Thomas A. McEachin, Mr. Ordan, Guy P. Sansone, John M. Starcher Jr., and Shirley A. Weis.

These announcements are pursuant to an agreement that MEDNAX has reached with Starboard Value LP and its affiliates, an investment firm that owns approximately 9.9% of MEDNAX’s outstanding common stock.

MEDNAX (NYSE: MD) is the nation’s leading provider of maternal-fetal, newborn, and pediatric subspecialty care.

For more information, please see the press release here.